相关产品推荐更多 >

NDUFB10抗体NDUFB10兔多抗抗体PDSW antibody抗体NDUFB10 Antibody抗体
¥440
USE1抗体USE1兔多抗抗体Vesicle transport protein USE1 antibody抗体USE1 Antibody, HRP conjugated抗体
¥880
CTTN抗体CTTN一抗抗体SRC8_HUMAN antibody抗体Phospho-CTTN (Y466) Antibody抗体
¥880
MIA2抗体MIA2兔多抗抗体MIA2_HUMAN antibody抗体MIA2 Antibody, HRP conjugated抗体
¥880
HOXB1抗体HOXB1兔多抗抗体MGC116845 antibody抗体HOXB1 Antibody抗体
¥440
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human KAAG1 protein
- 亚型:
hIgG1
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 克隆性:
Monoclonal
- 标记物:
Non-conjugated
- 适应物种:
Human
- 保质期:
Preservative: 0.03% Proclin 300<br />Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
- 抗原来源:
Homo sapiens (Human)
- 目录编号:
Q9UBP8
- 级别:
1
- 库存:
500
- 供应商:
武汉华美生物工程有限公司
- 应用范围:
ELISA
- 浓度:
Affinity-chromatography
- 靶点:
KAAG1
- 抗体英文名:
Kidney-associated antigen 1, RU2 antisense gene protein, KAAG1, RU2AS
- 抗体名:
KAAG1 Recombinant Monoclonal Antibody
- 规格:
100μl/50μl
| 规格: | 100μl | 产品价格: | ¥2200.0 |
|---|---|---|---|
| 规格: | 50μl | 产品价格: | ¥1320.0 |
Activity: Measured by its binding ability in a functional ELISA. Immobilized Human KAAG1(CSB-EP871385HU) at 2 \u03bcg\/mL can bind Anti-KAAG1 recombinant antibody.The EC50<\/sub> is 2.040-2.284 ng\/mL."}}
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Recombinant Monoclonal Antibodies
Recombinant antibody technology is a rapidly evolving field that enables the study and improvement of antibody properties by means of genetic engineering. Moreover, the functional expression of antibody fragments in Escherichia coli
Preparation and Testing of Monoclonal Antibodies to Recombinant Proteins
Monoclonal antibodies (MAbs) are essential reagents for the isolation, identification, and cellular localization of specific gene products and for aiding in the determination of their macromolecular structure. They can also help
Recombinant Genetic Libraries and Human Monoclonal Antibodies
-dominance in our selections to target a variety of epitopes per antigen. Together these methodologies allow us to produce human monoclonal antibodies to manipulate the human proteome.
技术资料暂无技术资料 索取技术资料






